Jindal Supreme IPO GMP

Listed

Jindal Supreme IPO GMP & Listing Price

Mainboard · ₹93 · 161 shares/lot · BSE, NSE

Final GMP before listing
₹26.5+28.5%
23 Sept, 3:37 pm
IST

Range so far: ₹11 low · ₹30 high

9 Sept23 Sept
Listed at
₹120
Listing gain / lot
+₹4,347
Cost / lot
₹14,973

GMP vs actual listing

GMP implied
+28.5%
Listed at
₹120
Actual
+29.0%

Closed its first day at ₹127.99 (+37.6% on the issue price)

Jindal Supreme carried a grey market premium of ₹26.5 on an issue price of ₹93, implying a listing around ₹119.5 (+28.5%). It opened at ₹120, +29.0% — almost exactly what the grey market implied.

The premium shown is the one published here before listing, frozen at the bell and never revised afterwards. See all 208 calls, including the misses.

Timeline

  1. Opens
    16 Sept
  2. Closes
    18 Sept
  3. Allotment
    21 Sept
  4. Listing
    23 Sept

Subscription status

as of 23 Sept, 3:37 pm
Total177.03x
Issue typeMainboard
Incorporated1974
SectorIron & Steel Products
Price₹93
Lot size161 shares
Min investment₹14,973
Issue size₹124.88 Cr
P/E ratio16.64
Face value₹10
RegistrarBigshare Services
ISININE1DLO01028
Listing atBSE, NSE
Listing dateWed, 23 Sept, 2026
NSE symbolJSIPL
BSE code544935

Official documents

Jindal Supreme IPO FAQs

What was the listing price of Jindal Supreme IPO?

Jindal Supreme IPO listed at ₹120 on Wed, 23 Sept, 2026, +29.0% against the issue price of ₹93, a gain of ₹4,347 on one lot of 161 shares. The last grey market premium before listing was ₹26.5, which implied ₹119.5.

What was the GMP of Jindal Supreme IPO before listing?

The last grey market premium for Jindal Supreme IPO was ₹26.5, recorded at 3:37 pm IST on Wed, 23 Sept, 2026. That implied +28.5% over the ₹93 price. The stock actually listed +29.0%, so GMP was off by 0.5%.

When was Jindal Supreme IPO allotment and listing?

Allotment for Jindal Supreme IPO was finalised on Mon, 21 Sept, 2026 and the shares listed on Wed, 23 Sept, 2026 on BSE, NSE. The registrar is Bigshare Services.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.